<page><tag>3</tag><title>Elan gets FDA approval for Tysabri MS treatment</title><text>LONDON (CBS.MW) -- Elan (UK:ELA) (ELN) and partner Biogen (BIIB) said the FDA has approved new drug Tysabri to treat relapsing forms of multiple sclerosis.</text></page>